ArticleBreast cancer research and treatment2017

Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients.

Briete Goorts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.